175 related articles for article (PubMed ID: 11310281)
41. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
42. Neuropsychological and electrophysiological indices of neurocognitive dysfunction in bipolar II disorder.
Andersson S; Barder HE; Hellvin T; Løvdahl H; Malt UF
Bipolar Disord; 2008 Dec; 10(8):888-99. PubMed ID: 19594504
[TBL] [Abstract][Full Text] [Related]
43. P300 and categorization in brand extension.
Ma Q; Wang X; Shu L; Dai S
Neurosci Lett; 2008 Jan; 431(1):57-61. PubMed ID: 18155837
[TBL] [Abstract][Full Text] [Related]
44. [Usefulness of P300 as a tool for diagnosing alterations in sustained attention in ischemic cerebrovascular disease].
Alonso-Prieto E; Alvarez-González MA; Fernández-Concepción O; Jiménez-Conde A; Machado C
Rev Neurol; 2002 Jun 16-30; 34(12):1105-9. PubMed ID: 12134271
[TBL] [Abstract][Full Text] [Related]
45. [Topography of P300 in psychiatry--1. Cognitive P300 fields in psychoses].
Maurer K; Dierks T
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1988 Mar; 19(1):21-5. PubMed ID: 3131105
[TBL] [Abstract][Full Text] [Related]
46. The boundaries of schizophrenia.
Siever LJ; Kalus OF; Keefe RS
Psychiatr Clin North Am; 1993 Jun; 16(2):217-44. PubMed ID: 8332562
[TBL] [Abstract][Full Text] [Related]
47. P300 alterations in schizophrenic patients experiencing auditory hallucinations.
Papageorgiou C; Oulis P; Vasios C; Kontopantelis E; Uzunoglu N; Rabavilas A; Christodoulou GN
Eur Neuropsychopharmacol; 2004 May; 14(3):227-36. PubMed ID: 15056482
[TBL] [Abstract][Full Text] [Related]
48. P300 subcomponent abnormalities in schizophrenia: III. Deficits In unaffected siblings of schizophrenic probands.
Turetsky BI; Cannon TD; Gur RE
Biol Psychiatry; 2000 Mar; 47(5):380-90. PubMed ID: 10704950
[TBL] [Abstract][Full Text] [Related]
49. P300, a state and a trait marker in schizophrenia.
Blackwood D
Lancet; 2000 Mar; 355(9206):771-2. PubMed ID: 10711922
[No Abstract] [Full Text] [Related]
50. Decomposing P300 into correlates of genetic risk and current symptoms in schizophrenia: An inter-trial variability analysis.
Kim M; Lee TH; Kim JH; Hong H; Lee TY; Lee Y; Salisbury DF; Kwon JS
Schizophr Res; 2018 Feb; 192():232-239. PubMed ID: 28400070
[TBL] [Abstract][Full Text] [Related]
51. Segregation analysis of complex phenotypes: an application to schizophrenia and auditory P300 latency.
Sham PC; Morton NE; Muir WJ; Walker M; Collins A; Shields DC; St Clair DM; Blackwood DH
Psychiatr Genet; 1994; 4(1):29-38. PubMed ID: 8049901
[TBL] [Abstract][Full Text] [Related]
52. [Neurophysiological endophenotypes and schizophrenic disorder: emergence and evolution of a clinical concept].
Micoulaud Franchi JA; Vion Dury J; Cermolacce M
Encephale; 2012 Dec; 38 Suppl 3():S103-9. PubMed ID: 23279983
[TBL] [Abstract][Full Text] [Related]
53. [Features of cognitive audiory evoked potentials changes at participants of liquidation of chernobyl accident consequences the message II. the analysis of late component P300].
Zhavoronkova LA; Belostotskiĭ AP; Kulikov MA; Kuptsova SV; Kholodova HB; Oknina LB
Fiziol Cheloveka; 2010; 36(4):22-33. PubMed ID: 20803948
[TBL] [Abstract][Full Text] [Related]
54. Cognitive event-related potential correlates of schizophrenia.
Pritchard WS
Psychol Bull; 1986 Jul; 100(1):43-66. PubMed ID: 2874579
[No Abstract] [Full Text] [Related]
55. Event-related brain potentials: a window on information processing in schizophrenia.
Duncan CC
Schizophr Bull; 1988; 14(2):199-203. PubMed ID: 2904693
[TBL] [Abstract][Full Text] [Related]
56. Long-term olanzapine treatment and p300 parameters in schizophrenia.
Molina V; Muñoz F; Martín-Loeches M; Casado P; Hinojosa JA; Iglesias A
Neuropsychobiology; 2004; 50(2):182-8. PubMed ID: 15292675
[TBL] [Abstract][Full Text] [Related]
57. [Biological markers in schizophrenia].
Lembreghts M; Ansseau M
Encephale; 1993; 19(5):501-23. PubMed ID: 8306920
[TBL] [Abstract][Full Text] [Related]
58. Effects of olanzapine on auditory P300 in schizophrenia.
Gonul AS; Suer C; Coburn K; Ozesmi C; Oguz A; Yilmaz A
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):173-7. PubMed ID: 12551741
[TBL] [Abstract][Full Text] [Related]
59. What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia?
Korostenskaja M; Kähkönen S
Curr Pharm Des; 2009; 15(22):2573-93. PubMed ID: 19689329
[TBL] [Abstract][Full Text] [Related]
60. [Relationship between event-related potentials and brain injury].
Liu YQ; Zhang LL; Zhao XH
Fa Yi Xue Za Zhi; 2006 Oct; 22(5):374-7. PubMed ID: 17190155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
